Search results
AbbVie's tight grip on Humira market raises concerns about biosimilars By Reuters
Investing.com· 1 day agoHumira, which lists for almost $7,000 a month, is the first top-selling drug to compete with a slew...
7News' Tom Roussey emcees Crohn's and Colitis Foundation's Take Steps walk
WJLA· 7 days agoTom Roussey joins the crowd at the Take Steps walk, an event to raise money for the Crohn's and...
In Treating IBD, Consider Diet and Dentistry
Medscape· 3 days agoDr David Johnson highlights five compelling studies from this year's Digestive Disease Week exploring the role of oral health, diet, and intestinal...
DeSantis veto may mean help for hemp. Here’s why that could hurt marijuana legalization efforts in...
Florida Today via Yahoo News· 3 days agoCBD supporters say it helps with anxiety, insomnia, chronic pain, arthritis, Crohn's disease and...
I Asked 6 Bakers To Name the Best Boxed Brownie Mix—They All Said the Same Brand
Simply Recipes via Yahoo News· 2 days agoNeed a Gluten-Free Option? Miro spent years experimenting with gluten-free baking to manage his ...
AbbVie Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU - AbbVie (NYSE:ABBV), ALX Oncology...
Benzinga· 5 days agoThe recommended treatment regime with AbbVie's Skyrizi involves an intravenous induction dose of...
AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges...
Benzinga· 24 hours agoAbbVie Inc’s ABBV top-selling arthritis drug, Humira, has managed to retain over 80% of its patients even after facing nine lower-priced rivals in the U.S
AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
Zacks via Yahoo Finance· 5 days agoAbbVie (ABBV) announces that the EMA's CHMP issued a positive opinion on its regulatory filing...
Major Cause of IBD Discovered | Newswise
Newswise· 2 days agoAn estimated 3.1 million adults in the United States have been diagnosed with inflammatory bowel disease (IBD), which includes Crohn's disease& ...
AbbVie’s RINVOQ now indicated for paediatric arthritis in US
Pharmaceutical Technology via Yahoo Finance· 3 days agoRINVOQ is also being studied for a range of immune-mediated inflammatory diseases. Ongoing Phase III...
